Mark J. Ratain to Technology, Pharmaceutical
This is a "connection" page, showing publications Mark J. Ratain has written about Technology, Pharmaceutical.
Connection Strength
0.405
-
Biomarkers in early cancer drug development: limited utility. Clin Pharmacol Ther. 2009 Feb; 85(2):134-5.
Score: 0.336
-
From bedside to bench to bedside to clinical practice: an odyssey with irinotecan. Clin Cancer Res. 2006 Mar 15; 12(6):1658-60.
Score: 0.069